moderna covid - Search News

News

Moderna to cut 10% of global workforce

Moderna plans to slash 10% of workforce as COVID shot sales slow

Massachusetts-based Moderna said it plans to cut 10% of its global staff as part of its ongoing efforts to reduce annual operating expenses by around $1.5 billion by 2027.

Bloomberg on MSN · 4d

Moderna to Cut 10% of Staff to Offset Slowing Covid Business

Moderna Inc. is cutting about 10% of its workforce, part of an effort by the struggling biotech company to reduce spending as sales of its Covid vaccine decline.

invezz on MSN · 3d

Moderna to cut 10% of global workforce as Covid shot sales drop 20%

Moderna is reducing its global workforce by around 10% by the end of 2025 as demand for Covid-19 vaccines continues to weaken. The company, which had about 5,800 full-time employees across 18 countries as of 31 December 2024,

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

4don MSN

Pandemic darlings Moderna, BioNTech are now on two different paths

The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...

3don MSN

Moderna will lay off 10% of employees, Massachusetts-based company announces

Massachusetts-based Moderna, one of the companies at the forefront of developing a vaccine during the COVID pandemic, ...

1don MSN

Moderna to cut more than 800 jobs this year as it burns through cash

In a note to employees on Thursday, Moderna Inc. said it was laying off about 10% of its global workforce as part of the ...

Moderna falls as cost-cutting fails to appease investors

Moderna Inc. shares declined as the company’s cost-cutting efforts failed to assuage investors who are worried about the ...

2don MSN

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

Novavax Stock Dips As Moderna's Woes Weigh On Vaccine Sector

Shares of Novavax are trading lower Friday morning. The stock appears to be caught in a downdraft affecting COVID-19 vaccine ...

3don MSN

Moderna quarterly sales beat Street estimates on COVID booster sales, cost cuts

Moderna topped Wall Street sales expectations and reported a lower-than-expected second-quarter loss on Friday, driven by ...

ABC News3y

Moderna says its COVID booster increases antibody levels against ...

Moderna announced Monday that its COVID-19 vaccine booster increases antibody levels against the omicron variant within a month of getting the shot. In a lab study, the company gave 20 fully ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results